Manufacturers Life Insurance Company, The Aspira Women'S Health Inc. Transaction History

Manufacturers Life Insurance Company, The

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.4 - $1.09 $7,970 - $21,719	-19,926 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$0.88 - $1.81 $17,534 - $36,066	19,926 New	19,926 $20,000
Q1 2022 May 20, 2022	SELL	$0.88 - $1.81 $11,485 - $23,624	-13,052 Reduced 39.58%	19,926 $21,000
Q4 2021 Feb 16, 2022	SELL	$1.63 - $3.43 $13,680 - $28,787	-8,393 Reduced 20.29%	32,978 $58,000
Q3 2021 Nov 12, 2021	SELL	$3.19 - $5.48 $5,017 - $8,620	-1,573 Reduced 3.66%	41,371 $134,000
Q2 2021 Aug 12, 2021	SELL	$4.78 - $6.84 $28,718 - $41,094	-6,008 Reduced 12.27%	42,944 $241,000
Q1 2021 May 03, 2021	BUY	$5.9 - $9.13 $2,460 - $3,807	417 Added 0.86%	48,952 $330,000
Q4 2020 Feb 12, 2021	BUY	$3.0 - $6.71 $9,543 - $21,344	3,181 Added 7.01%	48,535 $326,000
Q3 2020 Nov 09, 2020	BUY	$2.54 - $4.56 $39,448 - $70,821	15,531 Added 52.08%	45,354 $140,000
Q2 2020 Aug 10, 2020	BUY	$0.78 - $5.25 $23,261 - $156,570	29,823 New	29,823 $123,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.